BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 29 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,869 | -54.2% | 45,057 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $32,441 | -39.9% | 45,057 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $54,000 | -8.5% | 45,057 | -9.5% | 0.00% | -50.0% |
| Q2 2022 | $59,000 | -45.4% | 49,797 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $108,000 | +45.9% | 49,797 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $74,000 | -49.0% | 49,797 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $145,000 | -17.1% | 49,797 | -6.1% | 0.00% | -33.3% |
| Q2 2021 | $175,000 | -12.1% | 53,041 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $199,000 | +6.4% | 53,041 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $187,000 | – | 53,041 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 500,000 | $1,881,000 | 0.06% |
| AJU IB Investment Co., Ltd. | 25,651 | $96,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $199,000 | 0.01% |
| Baker Brothers Advisors | 249,123 | $937,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $49,000 | 0.00% |
| Squarepoint Ops LLC | 27,915 | $105,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $23,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 13,300 | $50,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26 | $0 | 0.00% |